• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮性卵巢癌的外科治疗:文献综述

Surgical management of epithelial ovarian cancer: a review of the literature.

作者信息

Dupont N C, Berman M L

机构信息

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Irvine College of Medicine, Orange, CA 92697, USA.

出版信息

Minerva Ginecol. 2004 Dec;56(6):547-56.

PMID:15729207
Abstract

Epithelial ovarian cancer affects over 190,000 women worldwide. Over the past 40 years the median survival rate for women affected with this disease has increased from 12 months to 38 months. While advances in chemotherapy have enhanced our armamentarium, optimal cytoreductive surgery by well trained specialists offers the best opportunity for a long disease free interval.

摘要

上皮性卵巢癌影响着全球超过19万名女性。在过去40年里,患这种疾病的女性的中位生存率已从12个月提高到38个月。虽然化疗的进展增强了我们的治疗手段,但由训练有素的专家进行的最佳细胞减灭术为实现长无病生存期提供了最佳机会。

相似文献

1
Surgical management of epithelial ovarian cancer: a review of the literature.上皮性卵巢癌的外科治疗:文献综述
Minerva Ginecol. 2004 Dec;56(6):547-56.
2
Advances in treatment of epithelial ovarian cancer.上皮性卵巢癌的治疗进展
Nagoya J Med Sci. 2006 Jan;68(1-2):19-26.
3
Epithelial ovarian cancer: Does the time interval between primary surgery and postoperative chemotherapy have any prognostic importance?上皮性卵巢癌:初次手术与术后化疗之间的时间间隔有预后意义吗?
Acta Obstet Gynecol Scand. 2009;88(4):373-7. doi: 10.1080/00016340902814559.
4
[Time interval between ovarian cancer surgery and chemotherapy--secondary publication?].
Ugeskr Laeger. 2009 Nov 2;171(45):3265-8.
5
Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience.新辅助化疗后间隔细胞减灭术治疗不可切除的晚期上皮性卵巢癌患者:单中心经验。
Arch Gynecol Obstet. 2010 Oct;282(4):417-25. doi: 10.1007/s00404-009-1330-7. Epub 2009 Dec 25.
6
Optimal debulking surgery is an independent prognostic factor in patients with FIGO IIIC primary epithelial ovarian carcinoma.
Zhonghua Yi Xue Za Zhi (Taipei). 2000 Mar;63(3):220-5.
7
Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.挽救性细胞减灭术在铂类化疗后复发性卵巢癌患者治疗中的作用。
J Obstet Gynaecol Res. 2006 Dec;32(6):580-7. doi: 10.1111/j.1447-0756.2006.00460.x.
8
Recent advances in the management of women with ovarian cancer.卵巢癌女性患者管理的最新进展
Minerva Ginecol. 2004 Feb;56(1):81-9.
9
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.增加广泛的上腹部手术以实现最佳细胞减灭术可提高IIIC-IV期上皮性卵巢癌患者的生存率。
Gynecol Oncol. 2006 Dec;103(3):1083-90. doi: 10.1016/j.ygyno.2006.06.028. Epub 2006 Aug 4.
10
Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique).上皮性卵巢癌的保守治疗:GCCLCC(法国癌症防治中心外科医生小组)和SFOG(法国妇科肿瘤学会)多中心研究结果
Hum Reprod. 2005 May;20(5):1379-85. doi: 10.1093/humrep/deh777. Epub 2005 Apr 7.

引用本文的文献

1
The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer.血管内皮生长因子 C、基质金属蛋白酶-2 和 E-钙黏蛋白在卵巢上皮性癌中的相关性及其作用。
Med Oncol. 2012 Mar;29(1):318-23. doi: 10.1007/s12032-010-9817-4. Epub 2011 Jan 25.
2
Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma.与运动相关的辅肌动蛋白α-4与晚期和转移性卵巢癌相关。
Lab Invest. 2008 Jun;88(6):602-14. doi: 10.1038/labinvest.2008.25. Epub 2008 Mar 24.